West Nile virus
This article was originally published in The Gray Sheet
Executive Summary
Roche Diagnostics begins installing screening systems at five U.S. and Canadian sites to prepare for screening trials by July 1, the company says April 22. Roche's WNV entry is the TaqScreen WNV real-time PCR instrument (1"The Gray Sheet" March 17, 2003, p. 8)...
You may also be interested in...
West Nile Virus Assay Makers Race To Meet FDA’s Testing Needs By Summer
Focus Technologies expects to be the first company to offer a West Nile Virus clinical diagnostic in the U.S
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.